Is my portfolio
One Report to Answer all your Questions!
Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
902.15
10.60 (1.19%) Zydus Lifesciences informs about press release
Date: 19-02-2026Zydus Lifesciences has informed that it enclosed a copy of press release dated February 19, 2026, titled ‘Zydus launches biosimilar Aflibercept 2 mg ANYRA for advancing ophthalmic care’.
The above information is a part of company’s filings submitted to BSE.